CST7 and liver cancer: Moreover, it was disclosed that CST7 exhibited significant enrichment in cancer progenitors, liver cancer advancement, tumor evasion and tolerogenicity, late recurrence of liver cancer, and various subclasses of hepatocellular carcinoma [24].